| Year |
Citation |
Score |
| 2022 |
Garcia Jareño P, Bartley OJM, Precious SV, Rosser AE, Lelos MJ. Challenges in progressing cell therapies to the clinic for Huntington's disease: A review of the progress made with pluripotent stem cell derived medium spiny neurons. International Review of Neurobiology. 166: 1-48. PMID 36424090 DOI: 10.1016/bs.irn.2022.09.003 |
0.408 |
|
| 2022 |
Rosser AE, Busse ME, Gray WP, Aron Badin R, Perrier AL, Wheelock V, Cozzi E, Perpiña Martin U, Salado-Manzano C, Mills LJ, Drew C, Goldman SA, Canals JM, Thompson LM. Translating cell therapies for neurodegenerative diseases: Huntington's disease as a model disorder. Brain : a Journal of Neurology. PMID 35262656 DOI: 10.1093/brain/awac086 |
0.336 |
|
| 2021 |
Bartley OJM, Lelos MJ, Gray WP, Rosser AE. Do foetal transplant studies continue to be justified in Huntington's disease? Neuronal Signaling. 5: NS20210019. PMID 34956650 DOI: 10.1042/NS20210019 |
0.339 |
|
| 2021 |
Rizzo SA, Bartley O, Rosser AE, Newland B. Oxygen-glucose deprivation in neurons: implications for cell transplantation therapies. Progress in Neurobiology. 102126. PMID 34339808 DOI: 10.1016/j.pneurobio.2021.102126 |
0.34 |
|
| 2021 |
Drew CJG, Sharouf F, Randell E, Brookes-Howell L, Smallman K, Sewell B, Burrell A, Kirby N, Mills L, Precious S, Pallmann P, Gillespie D, Hood K, Busse M, Gray WP, ... Rosser A, et al. Protocol for an open label: phase I trial within a cohort of foetal cell transplants in people with Huntington's disease. Brain Communications. 3: fcaa230. PMID 33543141 DOI: 10.1093/braincomms/fcaa230 |
0.334 |
|
| 2020 |
Choompoo N, Bartley OJM, Precious SV, Vinh NN, Schnell C, Garcia A, Roberton VH, Williams NM, Kemp PJ, Kelly CM, Rosser AE. Induced pluripotent stem cells derived from the developing striatum as a potential donor source for cell replacement therapy for Huntington disease. Cytotherapy. PMID 33246883 DOI: 10.1016/j.jcyt.2020.06.001 |
0.316 |
|
| 2020 |
Bachoud-Lévi AC, Massart R, Rosser A. Cell therapy in Huntington's disease: taking stock of past studies to move the field forward. Stem Cells (Dayton, Ohio). PMID 33176057 DOI: 10.1002/stem.3300 |
0.411 |
|
| 2020 |
Casella C, Bourbon-Teles J, Bells S, Coulthard E, Parker GD, Rosser A, Jones DK, Metzler-Baddeley C. Drumming Motor Sequence Training Induces Apparent Myelin Remodelling in Huntington's Disease: A Longitudinal Diffusion MRI and Quantitative Magnetization Transfer Study. Journal of Huntington's Disease. PMID 32894249 DOI: 10.3233/Jhd-200424 |
0.326 |
|
| 2020 |
Salado-Manzano C, Perpiña U, Straccia M, Molina-Ruiz FJ, Cozzi E, Rosser AE, Canals JM. Is the Immunological Response a Bottleneck for Cell Therapy in Neurodegenerative Diseases? Frontiers in Cellular Neuroscience. 14: 250. PMID 32848630 DOI: 10.3389/Fncel.2020.00250 |
0.474 |
|
| 2020 |
Yhnell E, Furby H, Lowe RS, Brookes-Howell LC, Drew CJG, Playle R, Watson G, Metzler-Baddeley C, Rosser AE, Busse ME. A randomised feasibility study of computerised cognitive training as a therapeutic intervention for people with Huntington's disease (CogTrainHD). Pilot and Feasibility Studies. 6: 88. PMID 32577299 DOI: 10.1186/S40814-020-00623-Z |
0.301 |
|
| 2020 |
Casella C, Lipp I, Rosser A, Jones DK, Metzler-Baddeley C. A Critical Review of White Matter Changes in Huntington's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32537844 DOI: 10.1002/Mds.28109 |
0.37 |
|
| 2020 |
Precious SV, Smith GA, Heuer A, Jaeger I, Lane EL, Dunnett SB, Li M, Kelly CM, Rosser AE. Dopaminergic Progenitors Derived From Epiblast Stem Cells Function Similarly to Primary VM-Derived Progenitors When Transplanted Into a Parkinson's Disease Model. Frontiers in Neuroscience. 14: 312. PMID 32317925 DOI: 10.3389/Fnins.2020.00312 |
0.609 |
|
| 2020 |
Steventon JJ, Rosser AE, Hart E, Murphy K. Hypertension, Antihypertensive Use and the Delayed-Onset of Huntington's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32017180 DOI: 10.1002/Mds.27976 |
0.338 |
|
| 2020 |
Cronin T, Rosser A, Massey T. Clinical Presentation and Features of Juvenile-Onset Huntington's Disease: A Systematic Review. Journal of Huntington's Disease. 8: 171-179. PMID 31045518 DOI: 10.3233/Jhd-180339 |
0.342 |
|
| 2019 |
McLauchlan DJ, Lancaster T, Craufurd D, Linden DEJ, Rosser AE. Insensitivity to loss predicts apathy in huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31361357 DOI: 10.1002/Mds.27787 |
0.355 |
|
| 2019 |
Bachoud-Lévi AC, Ferreira J, Massart R, Youssov K, Rosser A, Busse M, Craufurd D, Reilmann R, De Michele G, Rae D, Squitieri F, Seppi K, Perrine C, Scherer-Gagou C, Audrey O, et al. International Guidelines for the Treatment of Huntington's Disease. Frontiers in Neurology. 10: 710. PMID 31333565 DOI: 10.3389/Fneur.2019.00710 |
0.337 |
|
| 2019 |
Drew CJG, Quinn L, Hamana K, Williams-Thomas R, Marsh L, Dimitropoulou P, Playle R, Griffin BA, Kelson M, Schubert R, Muratori L, Reilmann R, Rosser A, Busse M. Physical ACtivity and Exercise Outcomes in Huntington Disease (PACE-HD): Protocol for a 12-Month Trial Within Cohort Evaluation of a Physical Activity Intervention in People With Huntington Disease. Physical Therapy. PMID 31101920 DOI: 10.1093/Ptj/Pzz075 |
0.32 |
|
| 2019 |
Tabrizi SJ, Leavitt BR, Landwehrmeyer GB, Wild EJ, Saft C, Barker RA, Blair NF, Craufurd D, Priller J, Rickards H, Rosser A, Kordasiewicz HB, Czech C, Swayze EE, Norris DA, et al. Targeting Huntingtin Expression in Patients with Huntington's Disease. The New England Journal of Medicine. PMID 31059641 DOI: 10.1056/Nejmoa1900907 |
0.341 |
|
| 2019 |
Rosser A. Cell transplantation for neurological disorders Journal of Neurology, Neurosurgery, and Psychiatry. 67: 833C. PMID 10567514 DOI: 10.1136/Jnnp.67.6.833C |
0.408 |
|
| 2019 |
Abdulla M, Jathoul A, Rosser A, Gray W. FM2-6 Cell delivery for intracerebral cell transplantation Journal of Neurology, Neurosurgery & Psychiatry. 90: e25.1-e25. DOI: 10.1136/Jnnp-2019-Abn.78 |
0.38 |
|
| 2019 |
Mclauchlan D, Linden D, Rosser A. Impulsivity in Huntington's disease: Impaired decision-making and motor disinhibition European Neuropsychopharmacology. 29: S162-S163. DOI: 10.1016/J.Euroneuro.2018.11.283 |
0.309 |
|
| 2018 |
Bennasar M, Hicks YA, Clinch SP, Jones P, Holt C, Rosser A, Busse M. Automated Assessment of Movement Impairment in Huntington's Disease. Ieee Transactions On Neural Systems and Rehabilitation Engineering : a Publication of the Ieee Engineering in Medicine and Biology Society. 26: 2062-2069. PMID 30334742 DOI: 10.1109/Tnsre.2018.2868170 |
0.326 |
|
| 2018 |
Maxan A, Mason S, Saint-Pierre M, Smith E, Ho A, Harrower T, Watts C, Tai Y, Pavese N, Savage JC, Tremblay MÈ, Gould P, Rosser AE, Dunnett SB, Piccini P, et al. Outcome of cell suspension allografts in a patient with Huntington's disease. Annals of Neurology. PMID 30286516 DOI: 10.1002/Ana.25354 |
0.585 |
|
| 2018 |
Newland H, Eigel D, Rosser AE, Werner C, Newland B. Oxygen producing microscale spheres affect cell survival in conditions of oxygen-glucose deprivation in a cell specific manner: implications for cell transplantation. Biomaterials Science. PMID 30132477 DOI: 10.1039/C8Bm00490K |
0.331 |
|
| 2018 |
Clinch SP, Busse M, Lelos MJ, Rosser AE. Rethinking Functional Outcome Measures: The Development of a Novel Upper Limb Token Transfer Test to Assess Basal Ganglia Dysfunction. Frontiers in Neuroscience. 12: 366. PMID 29899687 DOI: 10.3389/Fnins.2018.00366 |
0.363 |
|
| 2018 |
Roberton VH, Rosser AE, McGorrian AM, Precious SV. Dissection and Preparation of Human Primary Fetal Ganglionic Eminence Tissue for Research and Clinical Applications. Methods in Molecular Biology (Clifton, N.J.). 1780: 573-583. PMID 29856036 DOI: 10.1007/978-1-4939-7825-0_26 |
0.432 |
|
| 2018 |
Telezhkin V, Straccia M, Yarova P, Pardo M, Yung S, Vinh NN, Hancock JM, Barriga GG, Brown DA, Rosser AE, Brown JT, Canals JM, Randall AD, Allen ND, Kemp PJ. Kv7 channels are upregulated during striatal neuron development and promote maturation of human iPSC-derived neurons. Pflugers Archiv : European Journal of Physiology. PMID 29797067 DOI: 10.1007/S00424-018-2155-7 |
0.324 |
|
| 2018 |
Ferrea S, Groiss SJ, Elben S, Hartmann CJ, Dunnett SB, Rosser A, Saft C, Schnitzler A, Vesper J, Wojtecki L. Pallidal deep brain stimulation in juvenile Huntington's disease: local field potential oscillations and clinical data. Journal of Neurology. PMID 29725840 DOI: 10.1007/S00415-018-8880-1 |
0.332 |
|
| 2018 |
Steventon JJ, Collett J, Furby H, Hamana K, Foster C, O'Callaghan P, Dennis A, Armstrong R, Németh AH, Rosser AE, Murphy K, Quinn L, Busse M, Dawes H. Alterations in the metabolic and cardiorespiratory response to exercise in Huntington's Disease. Parkinsonism & Related Disorders. PMID 29705557 DOI: 10.1016/J.Parkreldis.2018.04.014 |
0.301 |
|
| 2018 |
Harrison DJ, Roberton VH, Vinh NN, Brooks SP, Dunnett SB, Rosser AE. The Effect of Tissue Preparation and Donor Age on Striatal Graft Morphology in the Mouse. Cell Transplantation. 27: 230-244. PMID 29637815 DOI: 10.1177/0963689717744788 |
0.577 |
|
| 2018 |
Yhnell E, Furby H, Breen RS, Brookes-Howell LC, Drew CJG, Playle R, Watson G, Metzler-Baddeley C, Rosser AE, Busse ME. Exploring computerised cognitive training as a therapeutic intervention for people with Huntington's disease (CogTrainHD): protocol for a randomised feasibility study. Pilot and Feasibility Studies. 4: 45. PMID 29445514 DOI: 10.1186/S40814-018-0237-0 |
0.313 |
|
| 2018 |
Tabrizi SJ, Leavitt B, Landwehrmeyer B, Wild E, Saft C, Barker R, Craufurd D, Rickards H, Rosser A, Priller J, Kordasiewicz H, Czech C, Swayze E, Norris DA, Baumann T, et al. J01 Effects of IONIS-HTTRX (RG6042) in patients with early huntington’s disease, results of the first htt-lowering drug trial Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.261 |
0.353 |
|
| 2018 |
Abdulla M, Jathoul A, Vinh N, Zhu Y, Williams D, Messaritaki E, Murray J, Rosser A, Gray W. I23 Tracking transplanted human foetal cells using bioluminescence imaging in a huntington’s disease model Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.259 |
0.429 |
|
| 2018 |
Garcia A, Fjodorova M, Lelos MJ, Perrier AL, Michael M, Bugi A, Vinh N, Li M, Dunnett SB, Rosser AE. I21 Functional assessment of grafted human embryonic stem cells-derived progenitors in a rat model of huntington’s disease Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.257 |
0.608 |
|
| 2018 |
Massart R, Ferreira J, Youssov K, Rosser A, Busse M, Craufurd D, Reilmann R, Michele GD, Rae D, Squitieri F, Seppi K, Burgunder J, Bachoud-Lévi A. H01 Upcoming international guidelines in huntington’s disease Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.182 |
0.328 |
|
| 2018 |
McMillan I, McLauchlan D, Busse M, Bachoud-Lévi A, Reilmann R, Rosser A, Craufurd D. F57 Psychiatric symptoms in huntington’s disease: correlations between interview and self-report measures in the capit-hd2 beta-testing study Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.158 |
0.326 |
|
| 2018 |
McMillan I, McLauchlan D, Busse M, Bachoud-Lévi A, Reilmann R, Rosser A, Craufurd D. F56 Psychiatric symptoms in huntington’s disease: relationship to disease stage in the CAPIT-HD2 beta-testing study Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.157 |
0.374 |
|
| 2018 |
Massart R, Busse M, Craufurd D, Reilmann R, Rosser A, Bachoud-Lévi A. F55 Repair-hd project – WP5: preparation for clinical intervention Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.156 |
0.346 |
|
| 2018 |
Furby H, Ralph J, Rosser AE, O’Callaghan P, Murphy K, Wise RG, Steventon JJ. E08 Cerebral blood flow is associated with disease severity and cognitive defecits in pre/early huntington’s disease Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.102 |
0.322 |
|
| 2017 |
van de Zande NA, Massey TH, McLauchlan D, Pryce Roberts A, Zutt R, Wardle M, Payne GC, Clenaghan C, Tijssen MAJ, Rosser AE, Peall KJ. Clinical characterization of dystonia in adult patients with Huntington's disease. European Journal of Neurology. PMID 28661018 DOI: 10.1111/Ene.13349 |
0.38 |
|
| 2017 |
Bourbon-Teles J, Bells S, Jones DK, Coulthard E, Rosser A, Metzler-Baddeley C. Myelin breakdown in human Huntington's disease: Multi-modal evidence from diffusion MRI and quantitative magnetization transfer. Neuroscience. PMID 28579146 DOI: 10.1016/J.Neuroscience.2017.05.042 |
0.334 |
|
| 2017 |
Li M, Rosser AE. Pluripotent stem cell-derived neurons for transplantation in Huntington's disease. Progress in Brain Research. 230: 263-281. PMID 28552232 DOI: 10.1016/Bs.Pbr.2017.02.009 |
0.45 |
|
| 2017 |
Dunnett SB, Rosser AE. Reprogramming the diseased brain. Nature Biotechnology. 35: 426-428. PMID 28486448 DOI: 10.1038/Nbt.3869 |
0.53 |
|
| 2017 |
Precious SV, Zietlow R, Dunnett SB, Kelly CM, Rosser AE. Is there a place for human fetal-derived stem cells for cell replacement therapy in Huntington's disease? Neurochemistry International. PMID 28137534 DOI: 10.1016/J.Neuint.2017.01.016 |
0.613 |
|
| 2017 |
Martín-Ibáñez R, Guardia I, Pardo M, Herranz C, Zietlow R, Vinh NN, Rosser A, Canals JM. Insights in spatio-temporal characterization of human fetal neural stem cells. Experimental Neurology. PMID 28131724 DOI: 10.1016/J.Expneurol.2017.01.011 |
0.401 |
|
| 2016 |
Precious SV, Kelly CM, Allen ND, Rosser AE. Can manipulation of differentiation conditions eliminate proliferative cells from a population of ES cell-derived forebrain cells? Neurogenesis (Austin, Tex.). 3: e1127311. PMID 27606335 DOI: 10.1080/23262133.2015.1127311 |
0.317 |
|
| 2016 |
Steventon JJ, Trueman RC, Ma D, Yhnell E, Bayram-Weston Z, Modat M, Cardoso J, Ourselin S, Lythgoe M, Stewart A, Rosser AE, Jones DK. Longitudinal in vivo MRI in a Huntington's disease mouse model: Global atrophy in the absence of white matter microstructural damage. Scientific Reports. 6: 32423. PMID 27581950 DOI: 10.1038/Srep32423 |
0.346 |
|
| 2016 |
Fritz NE, Hamana K, Kelson M, Rosser A, Busse M, Quinn L. Motor-cognitive dual-task deficits in individuals with early-mid stage Huntington disease. Gait & Posture. 49: 283-289. PMID 27474949 DOI: 10.1016/J.Gaitpost.2016.07.014 |
0.335 |
|
| 2016 |
Quinn L, Hamana K, Kelson M, Dawes H, Collett J, Townson J, Roos R, van der Plas AA, Reilmann R, Frich JC, Rickards H, Rosser A, Busse M. A randomized, controlled trial of a multi-modal exercise intervention in Huntington's disease. Parkinsonism & Related Disorders. PMID 27423921 DOI: 10.1016/J.Parkreldis.2016.06.023 |
0.32 |
|
| 2016 |
Jones U, Busse M, Enright S, Rosser AE. Respiratory decline is integral to disease progression in Huntington's disease. The European Respiratory Journal. PMID 27338194 DOI: 10.1183/13993003.02215-2015 |
0.335 |
|
| 2016 |
Precious SV, Kelly CM, Reddington AE, Vinh NN, Stickland RC, Pekarik V, Scherf C, Jeyasingham R, Glasbey J, Holeiter M, Jones L, Taylor MV, Rosser AE. FoxP1 marks medium spiny neurons from precursors to maturity and is required for their differentiation. Experimental Neurology. PMID 27154297 DOI: 10.1016/J.Expneurol.2016.05.002 |
0.393 |
|
| 2016 |
Lelos MJ, Morgan RJ, Kelly CM, Torres EM, Rosser AE, Dunnett SB. Amelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's disease. Experimental Neurology. PMID 26851542 DOI: 10.1016/J.Expneurol.2016.02.003 |
0.552 |
|
| 2016 |
Townhill J, Hughes AC, Thomas B, Busse ME, Price K, Dunnett SB, Hastings MH, Rosser AE. Using Actiwatch to monitor circadian rhythm disturbance in Huntington' disease: a cautionary note. Journal of Neuroscience Methods. PMID 26774754 DOI: 10.1016/J.Jneumeth.2016.01.009 |
0.436 |
|
| 2016 |
Newland B, Wolff P, Zhou D, Wang W, Zhang H, Rosser A, Wang W, Werner C. Synthesis of ROS scavenging microspheres from a dopamine containing poly(β-amino ester) for applications for neurodegenerative disorders. Biomaterials Science. PMID 26756041 DOI: 10.1039/C5Bm00542F |
0.315 |
|
| 2016 |
Bartley O, Choompoo N, Vinh NN, Williams N, Precious S, Kelly C, Rosser A. L29 Utilising the intrinsic epigenetic memory of induced pluripotent stem cells to enhance cell replacement therapy for huntington’s disease Journal of Neurology, Neurosurgery & Psychiatry. 87: A100.1-A100. DOI: 10.1136/Jnnp-2016-314597.284 |
0.344 |
|
| 2016 |
Clinch S, Lelos M, Busse M, Rosser A. L28 Brain repair in huntington’s disease: optimizing and assessing graft functionality post transplantation Journal of Neurology, Neurosurgery & Psychiatry. 87: A99.3-A100. DOI: 10.1136/Jnnp-2016-314597.283 |
0.435 |
|
| 2016 |
Vinh N, Roberton VH, Schnell C, Allen ND, Kemp PJ, Kelly CM, Rosser AE. L26 A comparative study of human and mouse developing striatum for transplantation in huntington’s disease Journal of Neurology, Neurosurgery & Psychiatry. 87: A99.1-A99. DOI: 10.1136/Jnnp-2016-314597.281 |
0.394 |
|
| 2016 |
Rosser A. A18 Is cell replacement a feasible option for huntington’s disease Journal of Neurology, Neurosurgery & Psychiatry. 87: A5.4-A6. DOI: 10.1136/Jnnp-2016-314597.18 |
0.479 |
|
| 2016 |
McLauchlan D, Craufurd D, Linden D, Rosser A. G4 Limited insight? Objective testing of irritability in huntington’s disease Journal of Neurology, Neurosurgery & Psychiatry. 87: A55.3-A56. DOI: 10.1136/Jnnp-2016-314597.155 |
0.317 |
|
| 2016 |
McLauchlan D, Craufurd D, Linden D, Rosser A. G2 Huntington’s disease patients are ‘stuck in a rut’: objective testing of apathy in huntington’s disease Journal of Neurology, Neurosurgery & Psychiatry. 87: A55.1-A55. DOI: 10.1136/Jnnp-2016-314597.153 |
0.314 |
|
| 2016 |
de Zande NAv, Massey TH, McLauchlan D, Pryce Roberts A, Rosser AE, Peall KJ. E4 Clinical characterisation of dystonia in patients with huntington’s disease: Abstract E4 Table 1 Journal of Neurology, Neurosurgery & Psychiatry. 87: A46.2-A47. DOI: 10.1136/Jnnp-2016-314597.130 |
0.315 |
|
| 2016 |
Bennasar M, Hicks Y, Clinch S, Jones P, Rosser A, Busse M, Holt C. Huntington's Disease Assessment Using Tri Axis Accelerometers Procedia Computer Science. 96: 1193-1201. DOI: 10.1016/J.Procs.2016.08.163 |
0.317 |
|
| 2015 |
Lelos MJ, Roberton VH, Vinh NN, Harrison C, Eriksen P, Torres EM, Clinch SP, Rosser AE, Dunnett SB. Direct Comparison of Rat- and Human-Derived Ganglionic Eminence Tissue Grafts on Motor Function. Cell Transplantation. PMID 26727032 DOI: 10.3727/096368915X690297 |
0.577 |
|
| 2015 |
McCourt AC, O'Donovan KL, Ekblad E, Sand E, Craufurd D, Rosser A, Sanders D, Stoy N, Rickards H, Wierup N, Bates GP, Björkqvist M, Quarrell O. Characterization of Gastric Mucosa Biopsies Reveals Alterations in Huntington's Disease. Plos Currents. 7. PMID 26581667 DOI: 10.1371/Currents.Hd.858B4Cc7F235Df068387E9C20C436A79 |
0.33 |
|
| 2015 |
Straccia M, Garcia-Diaz Barriga G, Sanders P, Bombau G, Carrere J, Mairal PB, Vinh NN, Yung S, Kelly CM, Svendsen CN, Kemp PJ, Arjomand J, Schoenfeld RC, Alberch J, Allen ND, ... Rosser AE, et al. Quantitative high-throughput gene expression profiling of human striatal development to screen stem cell-derived medium spiny neurons. Molecular Therapy. Methods & Clinical Development. 2: 15030. PMID 26417608 DOI: 10.1038/Mtm.2015.30 |
0.387 |
|
| 2015 |
Liu D, Long JD, Zhang Y, Raymond LA, Marder K, Rosser A, McCusker EA, Mills JA, Paulsen JS. Motor onset and diagnosis in Huntington disease using the diagnostic confidence level. Journal of Neurology. PMID 26410751 DOI: 10.1007/S00415-015-7900-7 |
0.31 |
|
| 2015 |
Steventon JJ, Harrison DJ, Trueman RC, Rosser AE, Jones DK, Brooks SP. In Vivo MRI Evidence that Neuropathology is Attenuated by Cognitive Enrichment in the Yac128 Huntington's Disease Mouse Model. Journal of Huntington's Disease. 4: 149-60. PMID 26397896 DOI: 10.3233/Jhd-150147 |
0.335 |
|
| 2015 |
Wojtecki L, Groiss SJ, Ferrea S, Elben S, Hartmann CJ, Dunnett SB, Rosser A, Saft C, Südmeyer M, Ohmann C, Schnitzler A, Vesper J. A Prospective Pilot Trial for Pallidal Deep Brain Stimulation in Huntington's Disease. Frontiers in Neurology. 6: 177. PMID 26347707 DOI: 10.3389/Fneur.2015.00177 |
0.508 |
|
| 2015 |
Newland B, Welzel PB, Newland H, Renneberg C, Kolar P, Tsurkan M, Rosser A, Freudenberg U, Werner C. Tackling Cell Transplantation Anoikis: An Injectable, Shape Memory Cryogel Microcarrier Platform Material for Stem Cell and Neuronal Cell Growth. Small (Weinheim An Der Bergstrasse, Germany). 11: 5047-53. PMID 26237446 DOI: 10.1002/Smll.201500898 |
0.381 |
|
| 2015 |
Ferreira JJ, Rosser A, Craufurd D, Squitieri F, Mallard N, Landwehrmeyer B. Ethyl-eicosapentaenoic acid treatment in Huntington's disease: A placebo-controlled clinical trial. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1426-9. PMID 26175332 DOI: 10.1002/Mds.26308 |
0.355 |
|
| 2015 |
Roberton VH, Rosser AE, Kelly CM. Neonatal desensitization for the study of regenerative medicine. Regenerative Medicine. 10: 265-74. PMID 25933236 DOI: 10.2217/Rme.14.76 |
0.397 |
|
| 2015 |
Arber C, Precious SV, Cambray S, Risner-Janiczek JR, Kelly C, Noakes Z, Fjodorova M, Heuer A, Ungless MA, Rodríguez TA, Rosser AE, Dunnett SB, Li M. Activin A directs striatal projection neuron differentiation of human pluripotent stem cells. Development (Cambridge, England). 142: 1375-86. PMID 25804741 DOI: 10.1242/Dev.117093 |
0.571 |
|
| 2015 |
Reilmann R, Rouzade-Dominguez ML, Saft C, Süssmuth SD, Priller J, Rosser A, Rickards H, Schöls L, Pezous N, Gasparini F, Johns D, Landwehrmeyer GB, Gomez-Mancilla B. A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 427-31. PMID 25689146 DOI: 10.1002/Mds.26174 |
0.335 |
|
| 2015 |
Dawes H, Collett J, Debono K, Quinn L, Jones K, Kelson MJ, Simpson SA, Playle R, Backx K, Wasley D, Nemeth AH, Rosser A, Izardi H, Busse M. Exercise testing and training in people with Huntington's disease. Clinical Rehabilitation. 29: 196-206. PMID 25142278 DOI: 10.1177/0269215514540921 |
0.31 |
|
| 2015 |
Newland B, Newland H, Werner C, Rosser A, Wang W. Prospects for polymer therapeutics in Parkinson's disease and other neurodegenerative disorders Progress in Polymer Science. 44: 79-112. DOI: 10.1016/J.Progpolymsci.2014.12.002 |
0.312 |
|
| 2014 |
Reddington AE, Rosser AE, Dunnett SB. Differentiation of pluripotent stem cells into striatal projection neurons: a pure MSN fate may not be sufficient. Frontiers in Cellular Neuroscience. 8: 398. PMID 25520619 DOI: 10.3389/Fncel.2014.00398 |
0.605 |
|
| 2014 |
Hrastelj J, McLauchlan D, Rosser A, Clenaghan C. Ehypercalcaemia mimicking huntington’s disease: Lessons learned from delayed diagnosis Journal of the Royal College of Physicians of Edinburgh. 44: 286-288. PMID 25516897 DOI: 10.4997/Jrcpe.2014.407 |
0.33 |
|
| 2014 |
Busse M, Quinn L, Dawes H, Jones C, Kelson M, Poile V, Trubey R, Townson J, Edwards RT, Rosser A, Hood K. Supporting physical activity engagement in people with Huntington's disease (ENGAGE-HD): study protocol for a randomized controlled feasibility trial. Trials. 15: 487. PMID 25494622 DOI: 10.1186/1745-6215-15-487 |
0.342 |
|
| 2014 |
Metzler-Baddeley C, Cantera J, Coulthard E, Rosser A, Jones DK, Baddeley RJ. Improved Executive Function and Callosal White Matter Microstructure after Rhythm Exercise in Huntington's Disease. Journal of Huntington's Disease. 3: 273-83. PMID 25300331 DOI: 10.3233/Jhd-140113 |
0.392 |
|
| 2014 |
Rosser A, Svendsen CN. Stem cells for cell replacement therapy: a therapeutic strategy for HD? Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1446-54. PMID 25216372 DOI: 10.1002/Mds.26026 |
0.473 |
|
| 2014 |
Collett J, Esser P, Khalil H, Busse M, Quinn L, DeBono K, Rosser A, Nemeth AH, Dawes H. Insights into gait disorders: walking variability using phase plot analysis, Huntington's disease. Gait & Posture. 40: 694-700. PMID 25172806 DOI: 10.1016/J.Gaitpost.2014.08.001 |
0.33 |
|
| 2014 |
Rinaldi F, Hartfield EM, Crompton LA, Badger JL, Glover CP, Kelly CM, Rosser AE, Uney JB, Caldwell MA. Cross-regulation of Connexin43 and β-catenin influences differentiation of human neural progenitor cells. Cell Death & Disease. 5: e1017. PMID 24457961 DOI: 10.1038/Cddis.2013.546 |
0.331 |
|
| 2014 |
Dunnett SB, Rosser AE. Challenges for taking primary and stem cells into clinical neurotransplantation trials for neurodegenerative disease. Neurobiology of Disease. 61: 79-89. PMID 23688854 DOI: 10.1016/J.Nbd.2013.05.004 |
0.537 |
|
| 2014 |
Straccia M, Garcia G, Sanders P, Vinh N, Rosser A, Canals J. B14 High-throughput Gene Expression Analysis Of Human Striatal Nuclei Development In Control And Huntington's Disease Patients Journal of Neurology, Neurosurgery & Psychiatry. 85: A13-A14. DOI: 10.1136/Jnnp-2014-309032.42 |
0.374 |
|
| 2014 |
Reilmann R, Rouzade-Dominguez M, Saft C, Sussmuth S, Priller J, Rosser A, Rickards H, Schols L, Pezous N, Gasparini F, Landwehrmeyer G, Johns D, Gomez-Mancilla B. N03 Efficacy, Safety, And Tolerability Of Afq056 For The Treatment Of Chorea In Patients With Huntington's Disease Journal of Neurology, Neurosurgery & Psychiatry. 85: A102-A104. DOI: 10.1136/Jnnp-2014-309032.295 |
0.304 |
|
| 2014 |
Reilmann R, Squitieri F, Priller J, Saft C, Mariotti C, Sussmuth S, Nemeth A, Tabrizi S, Quarrell O, Craufurd D, Rickards H, Rosser A, Darpo B, Tessari M, Szynol A, et al. N02 Safety And Tolerability Of Selisistat For The Treatment Of Huntington's Disease: Results From A Randomised, Double-blind, Placebo-controlled Phase Ii Trial Journal of Neurology, Neurosurgery & Psychiatry. 85: A102-A102. DOI: 10.1136/Jnnp-2014-309032.294 |
0.319 |
|
| 2014 |
Clinch S, Rosser A, Lelos M, Busse M. N01 Cell Transplantation In Huntington's Disease Journal of Neurology, Neurosurgery & Psychiatry. 85: A101-A102. DOI: 10.1136/Jnnp-2014-309032.293 |
0.437 |
|
| 2014 |
Martin-Ibanez R, Pardo M, Guardia I, Kelly C, Herranz C, Vinh N, Rosser A, Canals J. M18 Spatio-temporal Characterisation Of Human Fetal Neural Stem Cells For Cell Replacement Therapies Journal of Neurology, Neurosurgery & Psychiatry. 85: A100-A101. DOI: 10.1136/Jnnp-2014-309032.290 |
0.399 |
|
| 2014 |
Jones K, Debono K, Quinn L, Rosser A, Busse M. J09 Physiotherapy Task Orientated Approach: A Case Report Journal of Neurology, Neurosurgery & Psychiatry. 85: A68-A68. DOI: 10.1136/Jnnp-2014-309032.192 |
0.315 |
|
| 2014 |
Jones U, Busse M, Enright S, Rosser A. I11 Respiratory Function Decreases With Progression Of Huntington's Disease Journal of Neurology, Neurosurgery & Psychiatry. 85: A61-A62. DOI: 10.1136/Jnnp-2014-309032.173 |
0.308 |
|
| 2013 |
Roberton VH, Evans AE, Harrison DJ, Precious SV, Dunnett SB, Kelly CM, Rosser AE. Is the adult mouse striatum a hostile host for neural transplant survival? Neuroreport. 24: 1010-5. PMID 24257248 DOI: 10.1097/Wnr.0000000000000066 |
0.587 |
|
| 2013 |
Lelos MJ, Harrison DJ, Rosser AE, Dunnett SB. The lateral neostriatum is necessary for compensatory ingestive behaviour after intravascular dehydration in female rats. Appetite. 71: 287-94. PMID 24045209 DOI: 10.1016/J.Appet.2013.09.003 |
0.482 |
|
| 2013 |
Harrison DJ, Busse M, Openshaw R, Rosser AE, Dunnett SB, Brooks SP. Exercise attenuates neuropathology and has greater benefit on cognitive than motor deficits in the R6/1 Huntington's disease mouse model. Experimental Neurology. 248: 457-69. PMID 23911978 DOI: 10.1016/J.Expneurol.2013.07.014 |
0.515 |
|
| 2013 |
Barker RA, Mason SL, Harrower TP, Swain RA, Ho AK, Sahakian BJ, Mathur R, Elneil S, Thornton S, Hurrelbrink C, Armstrong RJ, Tyers P, Smith E, Carpenter A, Piccini P, ... ... Rosser AE, et al. The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 657-65. PMID 23345280 DOI: 10.1136/Jnnp-2012-302441 |
0.606 |
|
| 2013 |
Dalton A, Khalil H, Busse M, Rosser A, van Deursen R, Ólaighin G. Analysis of gait and balance through a single triaxial accelerometer in presymptomatic and symptomatic Huntington's disease. Gait & Posture. 37: 49-54. PMID 22819009 DOI: 10.1016/J.Gaitpost.2012.05.028 |
0.336 |
|
| 2013 |
Kelly CM, Battersby A, Rosser AE. Stem cell transplantation for neurodegenerative disease: A distant dream? Aging Health. 9: 139-148. DOI: 10.2217/Ahe.13.16 |
0.432 |
|
| 2013 |
Quinn L, Rosser A, Busse M. Critical features in the development of exercise-based interventions for people with huntington's disease European Neurological Review. 8: 10-13. DOI: 10.17925/Enr.2013.08.01.10 |
0.344 |
|
| 2012 |
Busse M, Khalil H, Brooks S, Quinn L, Rosser A. Practice, progress and future directions for physical therapies in Huntingtons disease. Journal of Huntington's Disease. 1: 175-85. PMID 25063330 DOI: 10.3233/Jhd-120025 |
0.304 |
|
| 2012 |
Rosser AE, Bachoud-Lévi AC. Clinical trials of neural transplantation in Huntington's disease. Progress in Brain Research. 200: 345-71. PMID 23195427 DOI: 10.1016/B978-0-444-59575-1.00016-8 |
0.455 |
|
| 2012 |
Precious SV, Rosser AE. Producing striatal phenotypes for transplantation in Huntington's disease. Experimental Biology and Medicine (Maywood, N.J.). 237: 343-51. PMID 22490511 DOI: 10.1258/Ebm.2011.011359 |
0.511 |
|
| 2012 |
Zietlow R, Precious SV, Kelly CM, Dunnett SB, Rosser AE. Long-term expansion of human foetal neural progenitors leads to reduced graft viability in the neonatal rat brain. Experimental Neurology. 235: 563-73. PMID 22475737 DOI: 10.1016/J.Expneurol.2012.03.010 |
0.571 |
|
| 2012 |
Dunnett SB, Heuer A, Lelos M, Brooks SP, Rosser AE. Bilateral striatal lesions disrupt performance in an operant delayed reinforcement task in rats. Brain Research Bulletin. 88: 251-60. PMID 21515345 DOI: 10.1016/J.Brainresbull.2011.04.002 |
0.46 |
|
| 2012 |
Dunnett SB, Fuller A, Rosser AE, Brooks SP. A novel extended sequence learning task (ESLeT) for rodents: validation and the effects of amphetamine, scopolamine and striatal lesions. Brain Research Bulletin. 88: 237-50. PMID 20969933 DOI: 10.1016/J.Brainresbull.2010.10.005 |
0.464 |
|
| 2012 |
Busse M, Quinn L, Debono K, Jones K, Collett J, Playle R, Kelly M, Backx K, Dawes H, Rosser AE, Hunt S, Nemeth A, Simpson S, Wasley D. A randomised feasibility study of a 12-week exercise programme in Huntington’s disease (HD) Journal of Neurology, Neurosurgery, and Psychiatry. 83. DOI: 10.1136/Jnnp-2012-303524.182 |
0.315 |
|
| 2012 |
Kelly CM, Roberton VH, Dunnett SB, Rosser AE. Reply to "neonatal desensitization does not universally prevent xenograft rejection" Nature Methods. 9: 858. DOI: 10.1038/Nmeth.2144 |
0.448 |
|
| 2011 |
de Yebenes JG, Landwehrmeyer B, Squitieri F, Reilmann R, Rosser A, Barker RA, Saft C, Magnet MK, Sword A, Rembratt A, Tedroff J. Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial. The Lancet. Neurology. 10: 1049-57. PMID 22071279 DOI: 10.1016/S1474-4422(11)70233-2 |
0.356 |
|
| 2011 |
Dunnett SB, Rosser AE. Clinical translation of cell transplantation in the brain. Current Opinion in Organ Transplantation. 16: 632-9. PMID 21926621 DOI: 10.1097/Mot.0B013E32834C2356 |
0.604 |
|
| 2011 |
Dunnett SB, Rosser AE. Cell-based treatments for huntington's disease. International Review of Neurobiology. 98: 483-508. PMID 21907097 DOI: 10.1016/B978-0-12-381328-2.00017-1 |
0.614 |
|
| 2011 |
Kelly CM, Precious SV, Torres EM, Harrison AW, Williams D, Scherf C, Weyrauch UM, Lane EL, Allen ND, Penketh R, Amso NN, Kemp PJ, Dunnett SB, Rosser AE. Medical terminations of pregnancy: a viable source of tissue for cell replacement therapy for neurodegenerative disorders. Cell Transplantation. 20: 503-13. PMID 21396160 DOI: 10.3727/096368910X546580 |
0.541 |
|
| 2011 |
Cordero-Llana O, Scott SA, Maslen SL, Anderson JM, Boyle J, Chowhdury RR, Tyers P, Barker RA, Kelly CM, Rosser AE, Stephens E, Chandran S, Caldwell MA. Clusterin secreted by astrocytes enhances neuronal differentiation from human neural precursor cells. Cell Death and Differentiation. 18: 907-13. PMID 21212797 DOI: 10.1038/Cdd.2010.169 |
0.36 |
|
| 2011 |
Rosser AE, Kelly CM, Dunnett SB. Cell transplantation for Huntingtons disease: Practical and clinical considerations Future Neurology. 6: 45-62. DOI: 10.2217/Fnl.10.78 |
0.605 |
|
| 2010 |
Madete JK, Klein A, Fuller A, Trueman RC, Rosser AE, Dunnett SB, Holt CA. Challenges facing quantification of rat locomotion along beams of varying widths. Proceedings of the Institution of Mechanical Engineers. Part H, Journal of Engineering in Medicine. 224: 1257-65. PMID 21218688 DOI: 10.1243/09544119JEIM779 |
0.4 |
|
| 2010 |
Döbrössy M, Busse M, Piroth T, Rosser A, Dunnett S, Nikkhah G. Neurorehabilitation with neural transplantation. Neurorehabilitation and Neural Repair. 24: 692-701. PMID 20647502 DOI: 10.1177/1545968310363586 |
0.564 |
|
| 2010 |
Quinn L, Busse M, Khalil H, Richardson S, Rosser A, Morris H. Client and therapist views on exercise programmes for early-mid stage Parkinson's disease and Huntington's disease Disability and Rehabilitation. 32: 917-928. PMID 19874213 DOI: 10.3109/09638280903362712 |
0.326 |
|
| 2010 |
Squitieri F, Landwehrmeyer GB, Garcia de Yebenes J, Reilmann R, Rosser A, Sword A, Rembratt Å, Tedroff J. L05 Huntexil (pridopidine) improves voluntary motor function in patients with Huntington's disease: results from the phase 3 study MermaiHD Journal of Neurology, Neurosurgery & Psychiatry. 81: A49-A49. DOI: 10.1136/Jnnp.2010.222687.5 |
0.305 |
|
| 2010 |
Jones U, Enright S, Busse M, Rosser A. J11 A pilot study on respiratory function in people with huntington's disease Journal of Neurology, Neurosurgery & Psychiatry. 81: A42.2-A43. DOI: 10.1136/Jnnp.2010.222661.11 |
0.326 |
|
| 2010 |
Hughes A, Price K, Mason D, Evans B, Pettit R, Evans W, Rosser A. F21 Is bone density altered in early stage huntington's disease patients?—a pilot study Journal of Neurology, Neurosurgery & Psychiatry. 81: A29.2-A29. DOI: 10.1136/Jnnp.2010.222620.21 |
0.309 |
|
| 2010 |
Khalil H, Dalton A, Deursen Rv, Rosser A, Laighin GÓ, Busse M. F17 The use of an accelerometer to evaluate the performance of timed up and go test in pre-symptomatic and symptomatic huntington's disease Journal of Neurology, Neurosurgery, and Psychiatry. 81. DOI: 10.1136/Jnnp.2010.222620.17 |
0.313 |
|
| 2009 |
Kelly CM, Handley OJ, Rosser AE. Human trials for neurodegenerative disease. Methods in Molecular Biology (Clifton, N.J.). 549: 33-47. PMID 19378194 DOI: 10.1007/978-1-60327-931-4_3 |
0.446 |
|
| 2009 |
Paynter SJ, Andrews KJ, Vinh NN, Kelly CM, Rosser AE, Amso NN, Dunnett SB. Membrane permeability coefficients of murine primary neural brain cells in the presence of cryoprotectant. Cryobiology. 58: 308-14. PMID 19285056 DOI: 10.1016/J.Cryobiol.2009.02.008 |
0.533 |
|
| 2009 |
Kelly CM, Precious SV, Scherf C, Penketh R, Amso NN, Battersby A, Allen ND, Dunnett SB, Rosser AE. Neonatal desensitization allows long-term survival of neural xenotransplants without immunosuppression. Nature Methods. 6: 271-3. PMID 19270699 DOI: 10.1038/Nmeth.1308 |
0.563 |
|
| 2009 |
Kelly CM, Dunnett SB, Rosser AE. Medium spiny neurons for transplantation in Huntington's disease. Biochemical Society Transactions. 37: 323-8. PMID 19143656 DOI: 10.1042/Bst0370323 |
0.608 |
|
| 2009 |
Busse ME, Wiles CM, Rosser AE. Mobility and falls in people with Huntington's disease Journal of Neurology, Neurosurgery and Psychiatry. 80: 88. PMID 19091714 DOI: 10.1136/Jnnp.2008.147793 |
0.317 |
|
| 2008 |
Lane EL, Handley OJ, Rosser AE, Dunnett SB. Potential cellular and regenerative approaches for the treatment of Parkinson's disease. Neuropsychiatric Disease and Treatment. 4: 835-45. PMID 19183776 DOI: 10.2147/Ndt.S2013 |
0.593 |
|
| 2008 |
Busse ME, Khalil H, Quinn L, Rosser AE. Physical therapy intervention for people with Huntington disease. Physical Therapy. 88: 820-31. PMID 18467429 DOI: 10.2522/Ptj.20070346 |
0.325 |
|
| 2008 |
Zietlow R, Lane EL, Dunnett SB, Rosser AE. Human stem cells for CNS repair. Cell and Tissue Research. 331: 301-22. PMID 17901985 DOI: 10.1007/S00441-007-0488-1 |
0.573 |
|
| 2007 |
Rosser AE, Zietlow R, Dunnett SB. Stem cell transplantation for neurodegenerative diseases. Current Opinion in Neurology. 20: 688-92. PMID 17992090 DOI: 10.1097/Wco.0B013E3282F132Fc |
0.573 |
|
| 2007 |
Varani K, Bachoud-Lévi AC, Mariotti C, Tarditi A, Abbracchio MP, Gasperi V, Borea PA, Dolbeau G, Gellera C, Solari A, Rosser A, Naji J, Handley O, Maccarrone M, Peschanski M, et al. Biological abnormalities of peripheral A(2A) receptors in a large representation of polyglutamine disorders and Huntington's disease stages. Neurobiology of Disease. 27: 36-43. PMID 17512749 DOI: 10.1016/J.Nbd.2007.03.011 |
0.33 |
|
| 2007 |
Joannides AJ, Webber DJ, Raineteau O, Kelly C, Irvine KA, Watts C, Rosser AE, Kemp PJ, Blakemore WF, Compston A, Caldwell MA, Allen ND, Chandran S. Environmental signals regulate lineage choice and temporal maturation of neural stem cells from human embryonic stem cells. Brain : a Journal of Neurology. 130: 1263-75. PMID 17472984 DOI: 10.1093/Brain/Awm070 |
0.409 |
|
| 2007 |
Kelly CM, Precious SV, Penketh R, Amso N, Dunnett SB, Rosser AE. Striatal graft projections are influenced by donor cell type and not the immunogenic background. Brain : a Journal of Neurology. 130: 1317-29. PMID 17395612 DOI: 10.1093/Brain/Awm053 |
0.565 |
|
| 2007 |
Busse ME, Rosser AE. Can directed activity improve mobility in Huntington's disease? Brain Research Bulletin. 72: 172-174. PMID 17352942 DOI: 10.1016/J.Brainresbull.2006.10.021 |
0.368 |
|
| 2007 |
Dunnett SB, Rosser AE. Cell transplantation for Huntington's disease Should we continue? Brain Research Bulletin. 72: 132-47. PMID 17352937 DOI: 10.1016/J.Brainresbull.2006.10.019 |
0.616 |
|
| 2007 |
Dunnett SB, Rosser AE. Stem cell transplantation for Huntington's disease. Experimental Neurology. 203: 279-92. PMID 17208230 DOI: 10.1016/J.Expneurol.2006.11.007 |
0.615 |
|
| 2007 |
Dunnett SB, Rosser AE. Neural Transplantation in Parkinson's Disease Cellular Transplantation. 439-454. DOI: 10.1016/B978-012369415-7/50026-0 |
0.521 |
|
| 2006 |
Farrington M, Wreghitt TG, Lever AM, Dunnett SB, Rosser AE, Barker RA. Neural transplantation in Huntington's disease: the NEST-UK donor tissue microbiological screening program and review of the literature. Cell Transplantation. 15: 279-94. PMID 16898222 DOI: 10.3727/000000006783981927 |
0.54 |
|
| 2006 |
Rosser AE, Dunnett SB. Cell transplantation for Huntington's disease. The Lancet. Neurology. 5: 284-5. PMID 16545739 DOI: 10.1016/S1474-4422(06)70385-4 |
0.589 |
|
| 2006 |
Handley OJ, Naji JJ, Dunnett SB, Rosser AE. Pharmaceutical, cellular and genetic therapies for Huntington's disease. Clinical Science (London, England : 1979). 110: 73-88. PMID 16336206 DOI: 10.1042/Cs20050148 |
0.543 |
|
| 2005 |
Kelly CM, Tyers P, Borg MT, Svendsen CN, Dunnett SB, Rosser AE. EGF and FGF-2 responsiveness of rat and mouse neural precursors derived from the embryonic CNS. Brain Research Bulletin. 68: 83-94. PMID 16325008 DOI: 10.1016/J.Brainresbull.2005.08.020 |
0.513 |
|
| 2005 |
Zietlow R, Pekarik V, Armstrong RJ, Tyers P, Dunnett SB, Rosser AE. The survival of neural precursor cell grafts is influenced by in vitro expansion. Journal of Anatomy. 207: 227-40. PMID 16185247 DOI: 10.1111/J.1469-7580.2005.00449.X |
0.563 |
|
| 2005 |
Rosser A. Brain repair: Moving along Brain Research Bulletin. 68: 1-3. DOI: 10.1016/J.Brainresbull.2005.09.006 |
0.417 |
|
| 2004 |
Dunnett SB, Rosser AE. Cell therapy in Huntington's disease. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 1: 394-405. PMID 15717043 DOI: 10.1602/Neurorx.1.4.394 |
0.592 |
|
| 2003 |
Rosser AE, Barker RA, Armstrong RJE, Elneil S, Jain M, Hurelbrink CB, Prentice A, Carne C, Thornton S, Hutchinson H, Dunnett SB. Staging and Preparation of Human Fetal Striatal Tissue for Neural Transplantation in Huntington's Disease. Cell Transplantation. 12: 679-686. PMID 28858589 DOI: 10.3727/000000003108747299 |
0.545 |
|
| 2003 |
Hurelbrink CB, Tyers P, Armstrong RJE, Dunnett SB, Barker RA, Rosser AE. Long-Term Hibernation of Human Fetal Striatal Tissue does Not Adversely Affect its Differentiation In Vitro or Graft Survival: Implications for Clinical Trials in Huntington's Disease. Cell Transplantation. 12: 687-695. PMID 28858586 DOI: 10.3727/000000003108747307 |
0.516 |
|
| 2003 |
Hurelbrink CB, Tyers P, Armstrong RJ, Dunnett SB, Barker RA, Rosser AE. Long-term hibernation of human fetal striatal tissue does not adversely affect its differentiation in vitro or graft survival: implications for clinical trials in Huntington's disease. Cell Transplantation. 12: 687-95. PMID 14653616 DOI: 10.3727/000000003108747307 |
0.572 |
|
| 2003 |
Rosser AE, Barker RA, Armstrong RJ, Elneil S, Jain M, Hurelbrink CB, Prentice A, Carne C, Thornton S, Hutchinson H, Dunnett SB. Staging and preparation of human fetal striatal tissue for neural transplantation in Huntington's disease. Cell Transplantation. 12: 679-86. PMID 14653615 DOI: 10.3727/000000003108747299 |
0.598 |
|
| 2003 |
Rosser AE, Dunnett SB. Neural transplantation in patients with Huntington's disease. Cns Drugs. 17: 853-67. PMID 12962526 DOI: 10.2165/00023210-200317120-00001 |
0.623 |
|
| 2003 |
Ho AK, Manly T, Nestor PJ, Sahakian BJ, Bak TH, Robbins TW, Rosser AE, Barker RA. A case of unilateral neglect in Huntington's disease. Neurocase. 9: 261-73. PMID 12925932 DOI: 10.1076/Neur.9.3.261.15559 |
0.303 |
|
| 2003 |
Jain M, Armstrong RJ, Elneil S, Rosser AE, Barker RA. Migration and differentiation of transplanted human neural precursor cells. Neuroreport. 14: 1257-62. PMID 12824771 DOI: 10.1097/00001756-200307010-00014 |
0.422 |
|
| 2003 |
Jain M, Armstrong RJ, Tyers P, Barker RA, Rosser AE. GABAergic immunoreactivity is predominant in neurons derived from expanded human neural precursor cells in vitro. Experimental Neurology. 182: 113-23. PMID 12821381 DOI: 10.1016/S0014-4886(03)00055-4 |
0.351 |
|
| 2003 |
Kelly CM, Zietlow R, Dunnett SB, Rosser AE. The effects of various concentrations of FGF-2 on the proliferation and neuronal yield of murine embryonic neural precursor cells in vitro. Cell Transplantation. 12: 215-23. PMID 12797376 DOI: 10.3727/000000003108746777 |
0.526 |
|
| 2003 |
Armstrong RJ, Tyers P, Jain M, Richards A, Dunnett SB, Rosser AE, Barker RA. Transplantation of expanded neural precursor cells from the developing pig ventral mesencephalon in a rat model of Parkinson's disease. Experimental Brain Research. 151: 204-17. PMID 12783147 DOI: 10.1007/S00221-003-1491-8 |
0.591 |
|
| 2003 |
Pavese N, Andrews TC, Brooks DJ, Ho AK, Rosser AE, Barker RA, Robbins TW, Sahakian BJ, Dunnett SB, Piccini P. Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study. Brain : a Journal of Neurology. 126: 1127-35. PMID 12690052 DOI: 10.1093/Brain/Awg119 |
0.5 |
|
| 2002 |
Rosser AE, Barker RA, Harrower T, Watts C, Farrington M, Ho AK, Burnstein RM, Menon DK, Gillard JH, Pickard J, Dunnett SB. Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. Journal of Neurology, Neurosurgery, and Psychiatry. 73: 678-85. PMID 12438470 DOI: 10.1136/Jnnp.73.6.678 |
0.594 |
|
| 2002 |
Armstrong RJ, Hurelbrink CB, Tyers P, Ratcliffe EL, Richards A, Dunnett SB, Rosser AE, Barker RA. The potential for circuit reconstruction by expanded neural precursor cells explored through porcine xenografts in a rat model of Parkinson's disease. Experimental Neurology. 175: 98-111. PMID 12009763 DOI: 10.1006/Exnr.2002.7889 |
0.573 |
|
| 2002 |
Hurelbrink CB, Armstrong RJ, Dunnett SB, Rosser AE, Barker RA. Neural cells from primary human striatal xenografts migrate extensively in the adult rat CNS. The European Journal of Neuroscience. 15: 1255-66. PMID 11982636 DOI: 10.1046/J.1460-9568.2002.01959.X |
0.598 |
|
| 2002 |
Rosser A, Dunnett S. New drugs for Huntington’s disease Neuroreport. 13: A21-A22. DOI: 10.1097/00001756-200202110-00001 |
0.517 |
|
| 2001 |
Armstrong RJ, Rosser AE, Dunnett SB, Barker RA. Neural stem cell technology as a novel treatment for Parkinson's disease. Methods in Molecular Medicine. 62: 289-307. PMID 21318784 DOI: 10.1385/1-59259-142-6:289 |
0.597 |
|
| 2001 |
Armstrong RJ, Harrower TP, Hurelbrink CB, McLaughin M, Ratcliffe EL, Tyers P, Richards A, Dunnett SB, Rosser AE, Barker RA. Porcine neural xenografts in the immunocompetent rat: immune response following grafting of expanded neural precursor cells. Neuroscience. 106: 201-16. PMID 11564430 DOI: 10.1016/S0306-4522(01)00273-1 |
0.571 |
|
| 2001 |
Jain M, Armstrong RJE, Barker RA, Rosser AE. Cellular and molecular aspects of striatal development Brain Research Bulletin. 55: 533-540. PMID 11543954 DOI: 10.1016/S0361-9230(01)00555-X |
0.312 |
|
| 2001 |
Hurelbrink CB, Armstrong RJ, Luheshi LM, Dunnett SB, Rosser AE, Barker RA. Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation. Experimental Neurology. 171: 46-58. PMID 11520120 DOI: 10.1006/Exnr.2001.7749 |
0.498 |
|
| 2001 |
Berrios GE, Wagle AC, Marková IS, Wagle SA, Ho LW, Rubinsztein DC, Whittaker J, Ffrench-Constant C, Kershaw A, Rosser A, Bak T, Hodges JR. Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington's disease gene carriers. Psychiatry Research. 102: 217-25. PMID 11440772 DOI: 10.1016/S0165-1781(01)00257-8 |
0.323 |
|
| 2001 |
Barker RA, Rosser AE. Neural transplantation therapies for Parkinson's and Huntington's diseases Drug Discovery Today. 6: 575-582. DOI: 10.1016/S1359-6446(01)01775-5 |
0.466 |
|
| 2000 |
Hurelbrink CB, Armstrong RJE, Barker RA, Dunnett SB, Rosser AE. Hibernated Human Fetal Striatal Tissue: Successful Transplantation in a Rat Model of Huntington's Disease. Cell Transplantation. 9: 743-749. PMID 28886291 DOI: 10.1177/096368970000900601 |
0.521 |
|
| 2000 |
Armstrong RJE, Watts C, Svendsen CN, Dunnett SB, Rosser AE. Survival, Neuronal Differentiation, and Fiber Outgrowth of Propagated Human Neural Precursor Grafts in an Animal Model of Huntington's Disease. Cell Transplantation. 9: 55-64. PMID 28876110 DOI: 10.1177/096368970000900108 |
0.564 |
|
| 2000 |
Hurelbrink CB, Armstrong RJ, Barker RA, Dunnett SB, Rosser AE. Hibernated human fetal striatal tissue: successful transplantation in a rat model of Huntington's disease. Cell Transplantation. 9: 743-9. PMID 11202561 DOI: 10.1177/096368970000900601 |
0.577 |
|
| 2000 |
Rosser AE, Ostenfeld T, Svendsen CN. Invited commentary: treatment of diseases of the central nervous system using encapsulated cells, by A. F. Hottinger and P. Aebischer (Advances and Technical Standards in Neurosurgery vol. 25). Advances and Technical Standards in Neurosurgery. 26: 125-8. PMID 10997199 DOI: 10.1007/978-3-7091-6323-8_4 |
0.321 |
|
| 2000 |
Rosser AE, Tyers P, Dunnett SB. The morphological development of neurons derived from EGF- and FGF-2-driven human CNS precursors depends on their site of integration in the neonatal rat brain. The European Journal of Neuroscience. 12: 2405-13. PMID 10947819 DOI: 10.1046/J.1460-9568.2000.00135.X |
0.551 |
|
| 2000 |
Watkins LH, Rogers RD, Lawrence AD, Sahakian BJ, Rosser AE, Robbins TW. Impaired planning but intact decision making in early Huntington's disease: implications for specific fronto-striatal pathology. Neuropsychologia. 38: 1112-25. PMID 10838146 DOI: 10.1016/S0028-3932(00)00028-2 |
0.301 |
|
| 2000 |
Armstrong RJ, Watts C, Svendsen CN, Dunnett SB, Rosser AE. Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's disease. Cell Transplantation. 9: 55-64. PMID 10784067 DOI: 10.1177/096368970000900108 |
0.614 |
|
| 1999 |
Andrews TC, Weeks RA, Turjanski N, Gunn RN, Watkins LH, Sahakian B, Hodges JR, Rosser AE, Wood NW, Brooks DJ. Huntington's disease progression. PET and clinical observations. Brain : a Journal of Neurology. 122: 2353-63. PMID 10581228 DOI: 10.1093/Brain/122.12.2353 |
0.316 |
|
| 1998 |
Svendsen CN, ter Borg MG, Armstrong RJ, Rosser AE, Chandran S, Ostenfeld T, Caldwell MA. A new method for the rapid and long term growth of human neural precursor cells. Journal of Neuroscience Methods. 85: 141-52. PMID 9874150 DOI: 10.1016/S0165-0270(98)00126-5 |
0.39 |
|
| 1998 |
Lawrence AD, Hodges JR, Rosser AE, Kershaw A, ffrench-Constant C, Rubinsztein DC, Robbins TW, Sahakian BJ. Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain : a Journal of Neurology. 121: 1329-41. PMID 9679784 DOI: 10.1093/Brain/121.7.1329 |
0.363 |
|
| 1998 |
Rosenblatt A, Ranen NG, Rubinsztein DC, Stine OC, Margolis RL, Wagster MV, Becher MW, Rosser AE, Leggo J, Hodges JR, ffrench-Constant CK, Sherr M, Franz ML, Abbott MH, Ross CA. Patients with features similar to Huntington's disease, without CAG expansion in huntingtin. Neurology. 51: 215-20. PMID 9674805 DOI: 10.1212/Wnl.51.1.215 |
0.341 |
|
| 1998 |
ROSSER A. Parkinson's Disease. (Advances in Neurology, Volume 69). Journal of Neurology, Neurosurgery & Psychiatry. 64: 141a-141a. DOI: 10.1136/Jnnp.64.1.141A |
0.359 |
|
| 1997 |
Watts C, Dunnett SB, Rosser AE. Effect of embryonic donor age and dissection on the DARPP-32 content of cell suspensions used for intrastriatal transplantation. Experimental Neurology. 148: 271-80. PMID 9398469 DOI: 10.1006/Exnr.1997.6646 |
0.573 |
|
| 1997 |
Svendsen CN, Caldwell MA, Shen J, ter Borg MG, Rosser AE, Tyers P, Karmiol S, Dunnett SB. Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease. Experimental Neurology. 148: 135-46. PMID 9398456 DOI: 10.1006/Exnr.1997.6634 |
0.6 |
|
| 1997 |
Svendsen CN, Skepper J, Rosser AE, ter Borg MG, Tyres P, Ryken T. Restricted growth potential of rat neural precursors as compared to mouse. Brain Research. Developmental Brain Research. 99: 253-8. PMID 9125479 DOI: 10.1016/S0165-3806(97)00002-3 |
0.308 |
|
| 1997 |
Rosser AE, Tyers P, ter Borg M, Dunnett SB, Svendsen CN. Co-expression of MAP-2 and GFAP in cells developing from rat EGF responsive precursor cells. Brain Research. Developmental Brain Research. 98: 291-5. PMID 9051273 DOI: 10.1016/S0165-3806(96)00189-7 |
0.474 |
|
| 1996 |
Lawrence AD, Sahakian BJ, Hodges JR, Rosser AE, Lange KW, Robbins TW. Executive and mnemonic functions in early Huntington's disease. Brain : a Journal of Neurology. 119: 1633-45. PMID 8931586 DOI: 10.1093/Brain/119.5.1633 |
0.348 |
|
| 1996 |
Svendsen CN, Clarke DJ, Rosser AE, Dunnett SB. Survival and differentiation of rat and human epidermal growth factor-responsive precursor cells following grafting into the lesioned adult central nervous system. Experimental Neurology. 137: 376-88. PMID 8635554 DOI: 10.1006/Exnr.1996.0039 |
0.588 |
|
| 1995 |
Svendsen CN, Rosser AE. Neurones from stem cells? Trends in Neurosciences. 18: 465-7. PMID 8592748 DOI: 10.1016/0166-2236(95)90045-4 |
0.342 |
|
| 1994 |
Rosser A, Hodges JR. Initial letter and semantic category fluency in Alzheimer's disease, Huntington's disease, and progressive supranuclear palsy. Journal of Neurology, Neurosurgery, and Psychiatry. 57: 1389-94. PMID 7964817 DOI: 10.1136/Jnnp.57.11.1389 |
0.351 |
|
| 1994 |
Rosser AE, Hodges JR. The Dementia Rating Scale in Alzheimer's disease, Huntington's disease and progressive supranuclear palsy Journal of Neurology. 241: 531-536. PMID 7799001 DOI: 10.1007/Bf00873515 |
0.313 |
|
| Show low-probability matches. |